Press release
North American Metabolic Disorder Therapeutics Market Growth, Size, Share, Industry Report and Forecast 2020-2026
North American metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.6% during the forecast period. Growing incidences of metabolic disorders are encouraging the growth of the market. An increasing prevalence of diabetes and obesity have been witnessed in the region owing to the sedentary lifestyle habits. As per the World Health Organization (WHO), since 1975, global obesity has nearly tripled. In 2016, over 1.9 million adults, aged 18 years and more were overweight and among these, 650 million were obese. In 2016, 39% of adults aged 18 years and more were overweight and 13% were obese. A sedentary lifestyle is a major factor for the rising incidence of metabolic syndrome in the region, characterized by low nutrient-dense, foods, and physical inactivity. During the early period of life, this exposure is most potent leads to childhood obesity which is a key risk factor for metabolic syndrome in adults. Rimonabant (Acomplia), dexfenfluramine (Redux), orlistat (Xenical), and sibutramine (Meridia, Reductil), have been registered to treat obesity. More drugs are in clinical trials for metabolic disorders treatment, which is expected to offer a potential scope for market growth.Request a Free Sample of our North American Metabolic Disorder Therapeutics Market: https://www.omrglobal.com/request-sample/north-american-metabolic-disorder-therapeutics-market
Scope of the North American Metabolic Disorder Therapeutics Market
Market Coverage
• The market number available for 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Therapy and Disease
• Countries Covered- US and Canada
• Competitive Landscape- AbbVie, Inc., Alexion Pharmaceuticals, Inc., Pfizer Inc., Eli Lilly & Co., and AstraZeneca plc
A full Report of North American Metabolic Disorder Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/north-american-metabolic-disorder-therapeutics-market
Recent Strategic Initiatives in the North American Metabolic Disorder Therapeutics Market
• In June 2020, Ultragenyx declared the US FDA approval of Dojolvi (triheptanoin). It is a source of fatty acids and calories to treat pediatric and adult patients suffering from long-chain fatty acid oxidation disorders (LC-FAOD). Dojolvi is a synthetic, highly purified, and 7-carbon fatty acid triglyceride particularly aimed to offer medium-chain, odd-carbon fatty acids as an energy source and metabolite replacement for people suffering from LC-FAOD.
• In March 2020, Eli Lilly and Co. declared the global licensing and research partnership with Sitryx, a biopharmaceutical company engaged in the development of therapeutics in immuno-inflammation and immuno-oncology. Under the partnership, the companies will study up to four new preclinical targets that are found by Sitryx that could result in potential new medicines for autoimmune diseases. Lilly will make a $10 million equity investment in Sitryx and Sitryx will get an upfront payment of $50 million.
Key questions addressed by the report
• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
North American Metabolic Disorder Therapeutics Market-Segmentation
By Therapy
• Drug Therapy
• Gene Therapy
• Cellular Transplantation
• Enzyme Replacement Therapy
• Others
By Disease
• Obesity
• Diabetes
• Lysosomal Storage Disease
• Hypercholesterolemia
• Others
North American Metabolic Disorder Therapeutics Market– Segment by Country
• US
• Canada
Company Profiles
• Abbvie Inc.
• Agios Pharmaceuticals Inc.
• Alexion Pharmaceuticals, Inc.
• Amgen Inc.
• Apotex Inc.
• BioMarin Pharmaceutical Inc.
• CymaBay Therapeutics, Inc.
• Dracen Pharmaceuticals, Inc.
• Eli Lilly and Co.
• Intra-Cellular Therapies, Inc.
• Pfizer Inc.
• Sigilon Therapeutics, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-metabolic-disorder-therapeutics-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North American Metabolic Disorder Therapeutics Market Growth, Size, Share, Industry Report and Forecast 2020-2026 here
News-ID: 2188669 • Views: …
More Releases from ORION MARKET RESEARCH

Compliance Management Software Market Size Analysis, Competitive Insights, Leadi …
The Compliance Management Software Market was valued at approximately USD 2.1 billion in 2023 and is projected to reach around USD 6.9 billion by 2033, reflecting a CAGR of about 12.5% from 2024 to 2033.
Compliance Management Software Market Overview
The Compliance Management Software Market is undergoing significant expansion as businesses across industries strive to keep pace with increasingly complex regulations and evolving cybersecurity risks. Adoption is being driven by digital transformation…

Artificial Womb Facility Market - Industry Trends and Forecast to 2033
The Artificial Womb Facility Market was valued at approximately USD 311 million in 2023, and based on a projected CAGR of about 12.3% from 2024 to 2033, the market can be expected to reach around USD 996 million by 2033.
Artificial Womb Facility Market Overview
The Artificial Womb Facility Market, centered on technologies such as extrauterine support systems (ectogenesis chambers), is witnessing rapid expansion. This growth is largely propelled by increasing rates…

Fuel Storage Tank Market: Emerging Trends and Growth Forecast to 2033
The Fuel Storage Tank Market was valued at approximately USD 14.8 billion in 2023 and is projected to reach around USD 22 billion by 2033, growing at a compound annual growth rate (CAGR) of about 4.5% from 2024 to 2033.
Fuel Storage Tank Market Overview
The Fuel Storage Tank Market is experiencing steady growth, driven by rising global energy demand, expanding industrialization, and the need for reliable fuel storage infrastructure. Regulations around…

Electrical & Electronic Plastics Market Overview: Growth, Share, Value, Size, an …
The Electrical & Electronic Plastics Market was valued at approximately USD 37.72 billion in 2023 and is projected to reach around USD 46.12 billion by 2033, reflecting a CAGR of about 5.2% from 2024 to 2033.
Electrical & Electronic Plastics Market Overview
The Electrical & Electronic Plastics Market is experiencing steady growth, fueled by rising demand for lightweight, durable, and electrically insulating materials across industries such as consumer electronics, automotive, and power…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…